Natus scales back Q2 revenue projections; GeneCentric raises $2.5M for cancer Dx development;

 @FierceMedDev: Roche chases FDA cancer indication for HPV diagnostic. Story | Follow @FierceMedDev

 @MarkHFierce: Duke has found early promise with a blood Dx that predicts aspirin treatment success. Report | Follow @MarkHFierce

 @DamianFierce: Patient lawsuits mount as India tries to crack down on unethical clinical trials. Item | Follow @DamianFierce

> Natus Medical ($BABY) has scaled back its second-quarter revenue projections by about 9%, expecting up to $82 million thanks to weak international sales. Release

> Terumo has started selling BSD Medical's ($BSDM) MicroThermX ablation system in Europe, following a licensing deal the two struck in the spring. News

> Diagnostics outfit GeneCentric has raised $2.5 million to develop cancer tests. Article

> Life Care Medical Devices has signed up with M.E.D. Surgical to distribute its Keyhole Cup laparoscopic access device in Ireland. Item

> Game developers are designing programs designed to treat mental disorders like depression and anxiety, but none has been approved by the FDA. Story

> Startup HeadSense has secured an undisclosed amount of financing to develop its non-invasive brain monitor for intracranial pressure. More

> Johns Hopkins physicians successfully used an endoscopy procedure to place a small metal stent in the stomach to treat patients who suffer from gastroparesis-related health problems. Item

> BD ($BDX) named Christopher Reidy as its new chief financial officer, a veteran ADP executive who also held similar roles at AT&T and Deloitte & Touche. Release

Biotech News

 @FierceBiotech: SEC hunting down traders who made a quick killing on Onyx shares. Report | Follow @FierceBiotech

 @JohnCFierce: Top Novartis blockbuster prospect whips Enbrel in psoriasis showdown. News | Follow @JohnCFierce

 @RyanMFierce: For those of you who remember Son of Lantus, watch out for Lantus' fraternal (not identical) twin from Lilly and Boehringer. | Follow @RyanMFierce

 @EmilyMFierce: Cholera is altering the human genome. Story | Follow @EmilyMFierce

> Swiss biotech OncoEthix snags $19M round to back leukemia drug study. More

> Cytokinetics shares slide on dosing snafu in ALS drug study. Article

> Top Novartis blockbuster prospect whips Enbrel in psoriasis showdown. Story

Pharma News

 @FiercePharma: Cost watchdogs veto Novartis breast cancer med Afinitor. NICE says "disappointed" data isn't stronger. News | Follow @FiercePharma

> Roche bids for broad use of HPV test to screen for cervical cancer. Story

> Lilly's Lechleiter returns to CEO suite after surgery. More

> Vivus, FMC both tout proxy advisers' support for board nominees. Article

> Medicare won't pay for Eli Lilly Alzheimer's agent. News

CRO News

> Report: Academia could better use CROs for early research. News

> Lawsuits mount as India pushes trial reforms. Article

> CRO Blue Sky taps new CEO amid growth. Story

> Parexel teams with Rutgers for clinical trials. More

> CROs shift as early-phase demand dries up. News

Biotech IT News

> Report: Pharma execs warm to med reminder apps. News

> GE, Accenture back analytics provider in $20M financing. Article

> Bioinformatics gives U. Wisconsin team an 'edge' in cystic fibrosis study. Story

> AstraZeneca snaps up drug-discovery software from Cambridge startup. More

> Facebook, Twitter bolster Canadian biotech's research of Crohn's therapy. News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.